Registro:

Referencias:

• Cho, M., Cummings, R.D., Galectin-1, a beta-galactoside-binding lectin in Chinese hamster ovary cells. II. Localization and biosynthesis (1995) J Biol Chem, 270 (10), pp. 5207-5212
• Lee, R.T., Ichikawa, Y., Allen, H.J., Lee, Y.C., Binding characteristics of galactoside-binding lectin (galaptin) from human spleen (1990) J Biol Chem, 265 (14), pp. 7864-7871
• Perillo, N.L., Marcus, M.E., Baum, L.G., Galectins: Versatile modulators of cell adhesion, cell proliferation, and cell death (1998) J Mol Med, 76 (6), pp. 402-412
• Camby, I., Le Mercier, M., Lefranc, F., Kiss, R., Galectin-1: A small protein with major functions (2006) Glycobiology, 16 (11), pp. 137R-157R
• Nickel, W., Unconventional secretory routes: Direct protein export across the plasma membrane of mammalian cells (2005) Traffic, 6 (8), pp. 607-614
• Yang, R.Y., Rabinovich, G.A., Liu, F.T., Galectins: Structure, function and therapeutic potential (2008) Expert Rev Mol Med, 10, p. e17
• Amano, M., Galvan, M., He, J., Baum, L.G., The ST6Gal i sialyltransferase selectively modifies N-glycans on CD45 to negatively regulate galectin-1-induced CD45 clustering, phosphatase modulation, and T cell death (2003) J Biol Chem, 278 (9), pp. 7469-7475
• Earl, L.A., Baum, L.G., CD45 glycosylation controls T-cell life and death (2008) Immunol Cell Biol, 86 (7), pp. 608-615
• Fulcher, J.A., Chang, M.H., Wang, S., Almazan, T., Hashimi, S.T., Eriksson, A.U., Wen, X., Lee, B., Galectin-1 co-clusters CD43/CD45 on dendritic cells and induces cell activation and migration through Syk and protein kinase C signaling (2009) J Biol Chem, 284 (39), pp. 26860-26870
• Hernandez, J.D., Nguyen, J.T., He, J., Wang, W., Ardman, B., Green, J.M., Fukuda, M., Baum, L.G., Galectin-1 binds different CD43 glycoforms to cluster CD43 and regulate T cell death (2006) J Immunol, 177 (8), pp. 5328-5336
• Nguyen, J.T., Evans, D.P., Galvan, M., Pace, K.E., Leitenberg, D., Bui, T.N., Baum, L.G., CD45 modulates galectin-1-induced T cell death: Regulation by expression of core 2 O-glycans (2001) J Immunol, 167 (10), pp. 5697-5707
• Croci, D.O., Salatino, M., Rubinstein, N., Cerliani, J.P., Cavallin, L.E., Leung, H.J., Ouyang, J., Rabinovich, G.A., Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma (2012) J Exp Med, 209 (11), pp. 1985-2000
• Toscano, M.A., Bianco, G.A., Ilarregui, J.M., Croci, D.O., Correale, J., Hernandez, J.D., Zwirner, N.W., Rabinovich, G.A., Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death (2007) Nat Immunol, 8 (8), pp. 825-834
• Grigorian, A., Torossian, S., Demetriou, M., T-cell growth, cell surface organization, and the galectin-glycoprotein lattice (2009) Immunol Rev, 230 (1), pp. 232-246
• Leppanen, A., Stowell, S., Blixt, O., Cummings, R.D., Dimeric galectin-1 binds with high affinity to alpha2, 3-sialylated and non-sialylated terminal N-acetyllactosamine units on surface-bound extended glycans (2005) J Biol Chem, 280 (7), pp. 5549-5562
• Song, X., Xia, B., Stowell, S.R., Lasanajak, Y., Smith, D.F., Cummings, R.D., Novel fluorescent glycan microarray strategy reveals ligands for galectins (2009) Chem Biol, 16 (1), pp. 36-47
• Stowell, S.R., Arthur, C.M., Mehta, P., Slanina, K.A., Blixt, O., Leffler, H., Smith, D.F., Cummings, R.D., Galectin-1,-2, and-3 exhibit differential recognition of sialylated glycans and blood group antigens (2008) J Biol Chem, 283 (15), pp. 10109-10123
• Barthel, S.R., Antonopoulos, A., Cedeno-Laurent, F., Schaffer, L., Hernandez, G., Patil, S.A., North, S.J., Dimitroff, C.J., Peracetylated 4-fluoro-glucosamine reduces the content and repertoire of N-and O-glycans without direct incorporation (2011) J Biol Chem, 286 (24), pp. 21717-21731
• Cho, M., Cummings, R.D., Characterization of monomeric forms of galectin-1 generated by site-directed mutagenesis (1996) Biochemistry, 35 (40), pp. 13081-13088
• Earl, L.A., Bi, S., Baum, L.G., Galectin multimerization and lattice formation are regulated by linker region structure (2011) Glycobiology, 21 (1), pp. 6-12
• Fuertes, M.B., Molinero, L.L., Toscano, M.A., Ilarregui, J.M., Rubinstein, N., Fainboim, L., Zwirner, N.W., Rabinovich, G.A., Regulated expression of galectin-1 during T-cell activation involves Lck and Fyn kinases and signaling through MEK1/ERK, p38 MAP kinase and p70S6 kinase (2004) Mol Cell Biochem, 267 (1-2), pp. 177-185
• Ilarregui, J.M., Croci, D.O., Bianco, G.A., Toscano, M.A., Salatino, M., Vermeulen, M.E., Geffner, J.R., Rabinovich, G.A., Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10 (2009) Nat Immunol, 10 (9), pp. 981-991
• Rabinovich, G.A., Iglesias, M.M., Modesti, N.M., Castagna, L.F., Wolfenstein-Todel, C., Riera, C.M., Sotomayor, C.E., Activated rat macrophages produce a galectin-1-like protein that induces apoptosis of T cells: Biochemical and functional characterization (1998) J Immunol, 160 (10), pp. 4831-4840
• Rabinovich, G.A., Toscano, M.A., Turning 'sweet' on immunity: Galectin-glycan interactions in immune tolerance and inflammation (2009) Nat Rev Immunol, 9 (5), pp. 338-352
• Zuniga, E., Rabinovich, G.A., Iglesias, M.M., Gruppi, A., Regulated expression of galectin-1 during B-cell activation and implications for T-cell apoptosis (2001) J Leukocyte Biol, 70 (1), pp. 73-79
• Juszczynski, P., Ouyang, J., Monti, S., Rodig, S.J., Takeyama, K., Abramson, J., Chen, W., Shipp, M.A., The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma (2007) Proc Natl Acad Sci USA, 104 (32), pp. 13134-13139
• Koopman, L.A., Kopcow, H.D., Rybalov, B., Boyson, J.E., Orange, J.S., Schatz, F., Masch, R., Strominger, J.L., Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential (2003) J Exp Med, 198 (8), pp. 1201-1212
• Kopcow, H.D., Rosetti, F., Leung, Y., Allan, D.S., Kutok, J.L., Strominger, J.L., T cell apoptosis at the maternal-fetal interface in early human pregnancy, involvement of galectin-1 (2008) Proc Natl Acad Sci USA, 105 (47), pp. 18472-18477
• Garner, O.B., Aguilar, H.C., Fulcher, J.A., Levroney, E.L., Harrison, R., Wright, L., Robinson, L.R., Baum, L.G., En-dothelial galectin-1 binds to specific glycans on nipah virus fusion protein and inhibits maturation, mobility, and function to block syncytia formation (2010) PLoS Pathog, 6 (7), p. e1000993
• Ito, K., Scott, S.A., Cutler, S., Dong, L.F., Neuzil, J., Blanchard, H., Ralph, S.J., Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregu-lation, angiogenesis and protection against oxidative stress (2011) Angiogenesis, 14 (3), pp. 293-307
• Mathieu, V., De Lassalle, E.M., Toelen, J., Mohr, T., Bellahcene, A., Van Goietsenoven, G., Verschuere, T., Feron, O., Galectin-1 in melanoma biology and related neo-angiogenesis processes (2012) J Invest Dermatol, 132 (9), pp. 2245-2254
• Thijssen, V.L., Hulsmans, S., Griffioen, A.W., The galectin profile of the endothelium: Altered expression and localization in activated and tumor endothelial cells (2008) Am J Pathol, 172 (2), pp. 545-553
• Thijssen, V.L., Postel, R., Brandwijk, R.J., Dings, R.P., Nesmelova, I., Satijn, S., Verhofstad, N., Griffioen, A.W., Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy (2006) Proc Natl Acad Sci USA, 103 (43), pp. 15975-15980
• Rabinovich, G., Castagna, L., Landa, C., Riera, C.M., Sotomayor, C., Regulated expression of a 16-kd galectin-like protein in activated rat macrophages (1996) J Leukocyte Biol, 59 (3), pp. 363-370
• Cedeno-Laurent, F., Watanabe, R., Teague, J.E., Kupper, T.S., Clark, R.A., Dimitroff, C.J., Galectin-1 inhibits the viability, proliferation, and Th1 cytokine production of nonmalignant T cells in patients with leukemic cutaneous T-cell lymphoma (2012) Blood, 119 (15), pp. 3534-3538
• Laderach, D.J., Gentilini, L., Giribaldi, L., Cardenas Delgado, V., Nugnes, L., Croci, D.O., Al Nakouzi, N., Rabinovich, G.A., A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease (2012) Cancer Res, 73 (1), pp. 86-96
• Rubinstein, N., Alvarez, M., Zwirner, N.W., Toscano, M.A., Ilarregui, J.M., Bravo, A., Mordoh, J., Rabinovich, G.A., Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection;A potential mechanism of tumor-immune privilege (2004) Cancer Cell, 5 (3), pp. 241-251
• Juszczynski, P., Rodig, S.J., Ouyang, J., O'Donnell, E., Takeyama, K., Mlynarski, W., Mycko, K., Shipp, M.A., MLL-rearranged B lymphoblastic leukemias selectively express the immunoregulatory carbohydrate-binding protein galectin-1 (2010) Clin Cancer Res, 16 (7), pp. 2122-2130
• Rodig, S.J., Ouyang, J., Juszczynski, P., Currie, T., Law, K., Neuberg, D.S., Rabinovich, G.A., Kutok, J.L., AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features (2008) Clin Cancer Res, 14 (11), pp. 3338-3344
• Ouyang, J., Juszczynski, P., Rodig, S.J., Green, M.R., O'Donnell, E., Currie, T., Armant, M., Shipp, M.A., Viral induction and targeted inhibition of galectin-1 in EBV + posttransplant lymphoproliferative disorders (2011) Blood, 117 (16), pp. 4315-4322
• Cedeno-Laurent, F., Opperman, M.J., Barthel, S.R., Hays, D., Schatton, T., Zhan, Q., He, X., Dimitroff, C.J., Metabolic inhibition of galectin-1-binding carbohydrates accentuates antitumor immunity (2012) J Invest Dermatol, 132 (2), pp. 410-420
• Demydenko, D., Berest, I., Expression of galectin-1 in malignant tumors (2009) Exp Oncol, 31 (2), pp. 74-79
• Jung, E.J., Moon, H.G., Cho, B.I., Jeong, C.Y., Joo, Y.T., Lee, Y.J., Hong, S.C., Park, S.T., Galectin-1 expression in cancer-associated stromal cells correlates tumor invasiveness and tumor progression in breast cancer (2007) Int J Cancer, 120 (11), pp. 2331-2338
• Kim, H.J., Jeon, H.K., Cho, Y.J., Park, Y.A., Choi, J.J., Do, I.G., Song, S.Y., Kim, B.G., High galectin-1 expression correlates with poor prognosis and is involved in epithelial ovarian cancer proliferation and invasion (2012) Eur J Cancer, 48 (12), pp. 1914-1921
• Jung, T.Y., Jung, S., Ryu, H.H., Jeong, Y.I., Jin, Y.H., Jin, S.G., Kim, I.Y., Kim, H.S., Role of galectin-1 in migration and invasion of human glioblastoma multiforme cell lines (2008) J Neurosurg, 109 (2), pp. 273-284
• Lefranc, F., Mathieu, V., Kiss, R., Galectin-1 as an oncotarget in gliomas and melanomas (2011) Oncotarget, 2 (12), pp. 892-893
• Rorive, S., Belot, N., Decaestecker, C., Lefranc, F., Gordower, L., Micik, S., Maurage, C.A., Camby, I., Galectin-1 is highly expressed in human gliomas with relevance for modulation of invasion of tumor astrocytes into the brain parenchyma (2001) Glia, 33 (3), pp. 241-255
• Toussaint, L.G., III, Nilson, A.E., Goble, J.M., Ballman, K.V., James, C.D., Lefranc, F., Kiss, R., Uhm, J.H., Galectin-1, a gene preferentially expressedatthe tumor margin, promotes glioblastoma cell invasion (2012) Mol Cancer, 11, p. 32
• Yamaoka, K., Mishima, K., Nagashima, Y., Asai, A., Sanai, Y., Kirino, T., Expression of galectin-1 mRNA correlates with the malignant potential of human gliomas and expression of antisense galectin-1 inhibits the growth of 9 glioma cells (2000) J Neurosci Res, 59 (6), pp. 722-730
• Blois, S.M., Ilarregui, J.M., Tometten, M., Garcia, M., Orsal, A.S., Cordo-Russo, R., Toscano, M.A., Arck, P.C., A pivotal role for galectin-1 in fetomaternal tolerance (2007) Nat Med, 13 (12), pp. 1450-1457
• Zacarias Fluck, M.F., Hess, L., Salatino, M., Croci, D.O., Stupirski, J.C., Di Masso, R.J., Roggero, E., Scharovsky, O.G., The aggressiveness of murine lymphomas selected in vivo by growth rate correlates with galectin-1 expression and response to cyclophosphamide (2012) Cancer Immunol Immun, 61 (4), pp. 469-480
• Jeschke, U., Toth, B., Scholz, C., Friese, K., Makrigiannakis, A., Glycoprotein and carbohydrate binding protein expression in the placenta in early pregnancy loss (2010) J Reprod Immunol, 85 (1), pp. 99-105
• Dalotto-Moreno, T., Croci, D.O., Cerliani, J.P., Martinez-Allo, V.C., Dergan-Dylon, S., Mendez Huergo, S.P., Stupirski, J.C., Salatino, M., Targeting galectin-1 overcomes breast cancer associated immunosup-pression and prevents metastatic disease (2012) Cancer Res, 73 (3), pp. 1107-1117
• Dimitroff, C.J., Sharma, A., Bernacki, R.J., Cancer metastasis: A search for therapeutic inhibition (1998) Cancer Invest, 16 (4), pp. 279-290
• Skrincosky, D.M., Allen, H.J., Bernacki, R.J., Galaptin-mediated adhesion of human ovarian carcinoma A121 cells and detection of cellular galaptin-binding glycoproteins (1993) Cancer Res, 53 (11), pp. 2667-2675
• Woynarowska, B., Skrincosky, D.M., Haag, A., Sharma, M., Matta, K., Bernacki, R.J., Inhibition of lectin-mediated ovarian tumor cell adhesion by sugar analogs (1994) J Biol Chem, 269 (36), pp. 22797-22803
• Liu, F.T., Rabinovich, G.A., Galectins: Regulators of acute and chronic inflammation (2010) Ann NY Acad Sci, 1183, pp. 158-182
• Rabinovich, G.A., Baum, L.G., Tinari, N., Paganelli, R., Natoli, C., Liu, F.T., Iacobelli, S., Galectins and their ligands: Amplifiers, silencers or tuners of the inflammatory response? (2002) Trends Immunol, 23 (6), pp. 313-320
• Rabinovich, G.A., Croci, D.O., Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer (2012) Immunity, 36 (3), pp. 322-335
• Baum, L.G., Blackall, D.P., Arias-Magallano, S., Nanigian, D., Uh, S.Y., Browne, J.M., Hoffmann, D., Baldwin, G.C., Amelioration of graft versus host disease by galectin-1 (2003) Clin Immunol, 109 (3), pp. 295-307
• Liu, S.D., Whiting, C.C., Tomassian, T., Pang, M., Bissel, S.J., Baum, L.G., Mossine, V.V., Miceli, M.C., Endogenous galectin-1 enforces class I-restricted TCR functional fate decisions in thymocytes (2008) Blood, 112 (1), pp. 120-130
• Motran, C.C., Molinder, K.M., Liu, S.D., Poirier, F., Miceli, M.C., Galectin-1 functions as a Th2 cytokine that selectively induces Th1 apoptosis and promotes Th2 function (2008) European J Immunol, 38 (11), pp. 3015-3027
• Vespa, G.N., Lewis, L.A., Kozak, K.R., Moran, M., Nguyen, J.T., Baum, L.G., Miceli, M.C., Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation (1999) J Immunol, 162 (2), pp. 799-806
• Thijssen, V.L., Barkan, B., Shoji, H., Aries, I.M., Mathieu, V., Deltour, L., Hackeng, T.M., Griffioen, A.W., Tumor cells secrete galectin-1 to enhance endothelial cell activity (2010) Cancer Res, 70 (15), pp. 6216-6224
• Salatino, M., Croci, D.O., Bianco, G.A., Ilarregui, J.M., Toscano, M.A., Rabinovich, G.A., Galectin-1 as a potential therapeutic target in autoimmune disorders and cancer (2008) Expert Opin Biol Ther, 8 (1), pp. 45-57
• Rabinovich, G.A., Ilarregui, J.M., Conveying glycan information into T-cell homeostatic programs: A challenging role for galectin-1 in inflammatory and tumor microenvironments (2009) Immunol Rev, 230 (1), pp. 144-159
• Rabinovich, G.A., Vidal, M., Galectins and microenvironmental niches during hematopoiesis (2012) Curr Opin Hematol, 18 (6), pp. 443-451
• Ramhorst, R.E., Giribaldi, L., Fraccaroli, L., Toscano, M.A., Stupirski, J.C., Romero, M.D., Durand, E.S., Rabinovich, G.A., Galectin-1 confers immune privilege to human trophoblast: Implications in recurrent fetal loss (2012) Glycobiology, 22 (10), pp. 1374-1386
• Von Gunten, S., Smith, D.F., Cummings, R.D., Riedel, S., Miescher, S., Schaub, A., Hamilton, R.G., Bochner, B.S., Intravenous immunoglobulin contains a broad repertoire of anti-carbohydrate antibodies that is not restricted to the IgG2 subclass (2009) J Allergy Clin Immun, 123 (6), pp. 1268-1268e15
• Cedeno-Laurent, F., Barthel, S.R., Opperman, M.J., Lee, D.M., Clark, R.A., Dimitroff, C.J., Development of a nascent galectin-1 chimeric molecule for studying the role of leukocyte galectin-1 ligands and immune disease modulation (2010) J Immunol, 185 (8), pp. 4659-4672
• Garin, M.I., Chu, C.C., Golshayan, D., Cernuda-Morollon, E., Wait, R., Lechler, R.I., Galectin-1: A key effector of regulation mediated by CD4 + CD25 + T cells (2007) Blood, 109 (5), pp. 2058-2065
• Tsai, C.M., Chiu, Y.K., Hsu, T.L., Lin, I.Y., Hsieh, S.L., Lin, K.I., Galectin-1 promotes immunoglobulin production during plasma cell differentiation (2008) J Immunol, 181 (7), pp. 4570-4579
• Cedeno-Laurent, F., Opperman, M., Barthel, S.R., Kuchroo, V.K., Dimitroff, C.J., Galectin-1 triggers an immunoregulatory signature in Th cells functionally defined by IL-10 expression (2012) J Immunol, 188 (7), pp. 3127-3137
• Van Der Leij, J., Van Den Berg, A., Blokzijl, T., Harms, G., Van Goor, H., Zwiers, P., Van Weeghel, R., Visser, L., Dimeric galectin-1 induces IL-10 production in T-lymphocytes: An important tool in the regulation of the immune response (2004) J Pathol, 204 (5), pp. 511-518
• Van Der Leij, J., Van Den Berg, A., Harms, G., Eschbach, H., Vos, H., Zwiers, P., Vanweeghel, R., Visser, L., Strongly enhanced IL-10 production using stable galectin-1 homodimers (2007) Mol Immunol, 44 (4), pp. 506-513
• Cho, M., Cummings, R.D., Galectin-1, a beta-galactoside-binding lectin in Chinese hamster ovary cells. I. Physical and chemical characterization (1995) J Biol Chem, 270 (10), pp. 5198-5206
• Stowell, S.R., Karmakar, S., Arthur, C.M., Ju, T., Rodrigues, L.C., Riul, T.B., Dias-Baruffi, M., Cummings, R.D., Galectin-1 induces reversible phosphatidylserine exposure at the plasma membrane (2009) Mol Biol Cell, 20 (5), pp. 1408-1418
• Stowell, S.R., Cho, M., Feasley, C.L., Arthur, C.M., Song, X., Colucci, J.K., Karmakar, S., Cummings, R.D., Ligand reduces galectin-1 sensitivity to oxidative inactivation by enhancing dimer formation (2009) J Biol Chem, 284 (8), pp. 4989-4999
• Tsai, C.M., Guan, C.H., Hsieh, H.W., Hsu, T.L., Tu, Z., Wu, K.J., Lin, C.H., Lin, K.I., Galectin-1 and galectin-8 have redundant roles in promoting plasma cell formation (2011) J Immunol, 187 (4), pp. 1643-1652
• Dias-Baruffi, M., Zhu, H., Cho, M., Karmakar, S., McEver, R.P., Cummings, R.D., Dimeric galectin-1 induces surface exposure of phosphatidylserine and phagocytic recognition of leukocytes without inducing apoptosis (2003) J Biol Chem, 278 (42), pp. 41282-41293
• Karmakar, S., Cummings, R.D., McEver, R.P., Contributions of Ca2 + to galectin-1-induced exposure of phosphatidylserine on activated neutrophils (2005) J Biol Chem, 280 (31), pp. 28623-28631
• Karmakar, S., Stowell, S.R., Cummings, R.D., McEver, R.P., Galectin-1 signaling in leukocytes requires expression of complex-type N-glycans (2008) Glycobiology, 18 (10), pp. 770-778
• Cedeno-Laurent, F., Dimitroff, C.J., Galectins and their ligands: Negative regulators of anti-tumor immunity (2012) Glycoconj J, 29 (8-9), pp. 619-625
• Cedeno-Laurent, F., Dimitroff, C.J., Galectin-1 research in T cell immunity: Past, present and future (2012) Clin Immunol, 142 (2), pp. 107-116
• Earl, L.A., Bi, S., Baum, L.G., N-and O-glycans modulate galectin-1 binding, CD45 signaling, and T cell death (2010) J Biol Chem, 285 (4), pp. 2232-2244
• Pace, K.E., Lee, C., Stewart, P.L., Baum, L.G., Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1 (1999) J Immunol, 163 (7), pp. 3801-3811
• Perillo, N.L., Pace, K.E., Seilhamer, J.J., Baum, L.G., Apoptosis of T cells mediated by galectin-1 (1995) Nature, 378 (6558), pp. 736-739
• Roberts, A.A., Amano, M., Felten, C., Galvan, M., Sulur, G., Pinter-Brown, L., Dobbeling, U., Baum, L.G., Galectin-1-mediated apoptosis in mycosis fun-goides: The roles of CD7 and cell surface glycosylation (2003) Mod Pathol, 16 (6), pp. 543-551
• Pang, M., He, J., Johnson, P., Baum, L.G., CD45-mediated fodrin cleavage during galectin-1 T cell death promotes phagocytic clearance of dying cells (2009) J Immunol, 182 (11), pp. 7001-7008
• Pace, K.E., Hahn, H.P., Pang, M., Nguyen, J.T., Baum, L.G., CD7 delivers a pro-apoptotic signal during galectin-1-induced T cell death (2000) J Immunol, 165 (5), pp. 2331-2334
• Walzel, H., Blach, M., Hirabayashi, J., Kasai, K.I., Brock, J., Involvement of CD2 and CD3 in galectin-1 induced signaling in human Jurkat T-cells (2000) Glycobiology, 10 (2), pp. 131-140
• Blaser, C., Kaufmann, M., Muller, C., Zimmermann, C., Wells, V., Mallucci, L., Pircher, H., Beta-galactoside-binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells (1998) Eur J Immunol, 28 (8), pp. 2311-2319
• Gandhi, M.K., Moll, G., Smith, C., Dua, U., Lambley, E., Ramuz, O., Gill, D., Khanna, R., Galectin-1 mediated suppression of Epstein-Barr virus specific T-cell immunity in classic Hodgkin lymphoma (2007) Blood, 110 (4), pp. 1326-1329
• Lanteri, M., Giordanengo, V., Hiraoka, N., Fuzibet, J.G., Auberger, P., Fukuda, M., Baum, L.G., Lefebvre, J.C., Altered T cell surface glycosylation in HIV-1 infection results in increased susceptibility to galectin-1-induced cell death (2003) Glycobiology, 13 (12), pp. 909-918
• Liu, S.D., Tomassian, T., Bruhn, K.W., Miller, J.F., Poirier, F., Miceli, M.C., Galectin-1 tunes TCR binding and signal transduction to regulate CD8 burst size (2009) J Immunol, 182 (9), pp. 5283-5295
• Ito, K., Ralph, S.J., Inhibiting galectin-1 reduces murine lung metastasis with increased CD4( + ) and CD8 ( + ) T cells and reduced cancer cell adherence (2012) Clin Exp Metastasis, 29 (6), pp. 561-572
• Chen, I.J., Chen, H.L., Demetriou, M., Lateral compartmentalization of T cell receptor versus CD45 by galectin-N-glycan binding and microfilaments coordinate basal and activation signaling (2007) J Biol Chem, 282 (48), pp. 35361-35372
• Carlow, D.A., Williams, M.J., Ziltener, H.J., Modulation of O-glycans and N-glycans on murine CD8 T cells fails to alter annexin v ligand induction by galectin 1 (2003) J Immunol, 171 (10), pp. 5100-5106
• Comelli, E.M., Sutton-Smith, M., Yan, Q., Amado, M., Panico, M., Gilmartin, T., Whisenant, T., Paulson, J.C., ActivationofmurineCD4+ and CD8 + T lymphocytes leads to dramatic remodeling of N-linked glycans (2006) J Immunol, 177 (4), pp. 2431-2440
• Antonopoulos, A., Demotte, N., Stroobant, V., Haslam, S.M., Van Der Bruggen, P., Dell, A., Loss of effector function of human cytolytic T lymphocytes is accompanied by major alterations in N-and O-glycosylation (2012) J Biol Chem, 287 (14), pp. 11240-11251
• Leppanen, A., Cummings, R.D., Fluorescence-based solid-phase assays to study glycan-binding protein interactions with glycoconjugates (2010) Methods Enzymol, 478, pp. 241-264
• Demetriou, M., Granovsky, M., Quaggin, S., Dennis, J.W., Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation (2001) Nature, 409 (6821), pp. 733-739
• Chen, H.L., Li, C.F., Grigorian, A., Tian, W., Demetriou, M., T cell receptor signaling co-regulates multiple Golgi genes to enhance N-glycan branching (2009) J Biol Chem, 284 (47), pp. 32454-32461
• Lau, K.S., Partridge, E.A., Grigorian, A., Silvescu, C.I., Reinhold, V.N., Demetriou, M., Dennis, J.W., Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation (2007) Cell, 129 (1), pp. 123-134
• Knibbs, R.N., Craig, R.A., Natsuka, S., Chang, A., Cameron, M., Lowe, J.B., Stoolman, L.M., The fucosyltransferase FucT-VII regulates E-selectin ligand synthesis in human T cells (1996) J Cell Biol, 133 (4), pp. 911-920
• Fuhlbrigge, R.C., Kieffer, J.D., Armerding, D., Kupper, T.S., Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells (1997) Nature, 389 (6654), pp. 978-981
• Wagers, A.J., Kansas, G.S., Potent induction of alpha(1, 3)-fucosyltransferase VII in activated CD4 + T cells byTGF-beta 1 through a p38 mitogen-activated protein kinase-dependent pathway (2000) J Immunol, 165 (9), pp. 5011-5016
• Weninger, W., Ulfman, L.H., Cheng, G., Souchkova, N., Quackenbush, E.J., Lowe, J.B., Vonandrian, U.H., Specialized contributions by alpha(1, 3)-fucosyltransferase-IV and FucT-VII during leukocyte rolling in dermal microvessels (2000) Immunity, 12 (6), pp. 665-676
• Erdmann, I., Scheidegger, E.P., Koch, F.K., Heinzerling, L., Odermatt, B., Burg, G., Lowe, J.B., Kundig, T.M., FucosyltransferaseVII-deficient mice with defective E-, P-, and L-selectin ligands show impaired CD4 + and CD8 + T cell migration into the skin, but normal extravasation into visceral organs (2002) J Immunol, 168 (5), pp. 2139-2146
• Dimitroff, C.J., Kupper, T.S., Sackstein, R., Prevention of leukocyte migration to inflamed skin with a novel fluorosugar modifier of cutaneous lymphocyte-associated antigen (2003) J Clin Invest, 112 (7), pp. 1008-1018
• Stannard, K.A., Collins, P.M., Ito, K., Sullivan, E.M., Scott, S.A., Gabutero, E., Darren Grice, I., Ralph, S.J., Galectin inhibitory disac-charides promote tumour immunity in a breast cancer model (2010) Cancer Lett, 299 (2), pp. 95-110
• Bernacki, R., Porter, C., Korytnyk, W., Mihich, E., Plasma membrane as a site for chemotherapeutic intervention (1977) Adv Enzyme Regul, 16, pp. 217-237
• Bernacki, R.J., Sharma, M., Porter, N.K., Rustum, Y., Paul, B., Korythyk, W., Biochemical characteristics, metabolism, and antitumor activity of several acetylated hexosamines (1977) J Supramol Struct, 7 (2), pp. 235-250
• Woynarowska, B., Dimitroff, C.J., Sharma, M., Matta, K.L., Bernacki, R.J., Inhibition of human HT-29 colon carcinoma cell adhesion by a 4-fluoro-glucosamine analogue (1996) Glycoconj J, 13 (4), pp. 663-674
• Descheny, L., Gainers, M.E., Walcheck, B., Dimitroff, C.J., Ameliorating skin-homing receptors on malignant T cells with a fluorosugar analog of N-acetylglucosamine: P-selectin ligand is a more sensitive target than E-selectin ligand (2006) J Invest Dermatol, 126 (9), pp. 2065-2073
• Dimitroff, C.J., Bernacki, R.J., Sackstein, R., Glycosylation-dependent inhibition of cutaneous lymphocyte-associated antigen expression: Implications in modulating lymphocyte migration to skin (2003) Blood, 101 (2), pp. 602-610
• Gainers, M.E., Descheny, L., Barthel, S.R., Liu, L., Wurbel, M.A., Dimitroff, C.J., Skin-homing receptors on effector leukocytes are differentially sensitive to glyco-metabolic antagonism in allergic contact dermatitis (2007) J Immunol, 179 (12), pp. 8509-8518
• Dimitroff, C.J., Leveraging fluorinated glucosamine action to boost antitumor immunity (2012) Curr Opin Immunol, 25 (2), pp. 206-213
• Dings, R.P., Van Der Schaft, D.W., Hargittai, B., Haseman, J., Griffioen, A.W., Mayo, K.H., Anti-tumor activity of the novel angiogenesis inhibitor anginex (2003) Cancer Lett, 194 (1), pp. 55-66
• Griffioen, A.W., Van Der Schaft, D.W., Barendsz-Janson, A.F., Cox, A., Struijker Boudier, H.A., Hillen, H.F., Mayo, K.H., Anginex, a designed peptide that inhibits angiogenesis (2001) Biochem J, 354, pp. 233-242
• Mayo, K.H., Van Der Schaft, D.W., Griffioen, A.W., Designed beta-sheet peptides that inhibit proliferation and induce apoptosis in endothelial cells (2001) Angiogenesis, 4 (1), pp. 45-51
• Salomonsson, E., Thijssen, V.L., Griffioen, A.W., Nilsson, U.J., Leffler, H., The anti-angiogenic peptide anginex greatly enhances galectin-1 binding affinity for glycoproteins (2011) J Biol Chem, 286 (16), pp. 13801-13804
• Perone, M.J., Bertera, S., Shufesky, W.J., Divito, S.J., Montecalvo, A., Mathers, A.R., Larregina, A.T., Morelli, A.E., Suppression of autoimmune diabetes by soluble galectin-1 (2009) J Immunol, 182 (5), pp. 2641-2653
• Rabinovich, G.A., Daly, G., Dreja, H., Tailor, H., Riera, C.M., Hirabayashi, J., Chernajovsky, Y., Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis (1999) J Exp Med, 190 (3), pp. 385-398
• Santucci, L., Fiorucci, S., Cammilleri, F., Servillo, G., Federici, B., Morelli, A., Galectin-1 exerts immunomodulatory and protective effects on concanavalin A-induced hepatitis in mice (2000) Hepatology, 31 (2), pp. 399-406
• Santucci, L., Fiorucci, S., Rubinstein, N., Mencarelli, A., Palazzetti, B., Federici, B., Rabinovich, G.A., Morelli, A., Galectin-1 suppresses experimental colitis in mice (2003) Gastroenterology, 124 (5), pp. 1381-1394
• Toscano, M.A., Commodaro, A.G., Ilarregui, J.M., Bianco, G.A., Liberman, A., Serra, H.M., Hirabayashi, J., Rabinovich, G.A., Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2-and T regulatory-mediated anti-inflammatory responses (2006) J Immunol, 176 (10), pp. 6323-6332
• Garrison, L., McDonnell, N.D., Etanercept: Therapeutic use in patients with rheumatoid arthritis (1999) Ann Rheum Dis, 58, pp. I65-I69
• Mikuls, T.R., Moreland, L.W., TNF blockadein the treatmentofrheumatoid arthritis: Inflix-imab versus etanercept (2001) Expert Opin Pharmacother, 2 (1), pp. 75-84
• El-Charabaty, E., Geara, A.S., Ting, C., El-Sayegh, S., Azzi, J., Belatacept: A new era of immunosuppression? (2012) Expert Rev Clin Immunol, 8 (6), pp. 527-536

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------